Dehradun-based startup Sunfox Technologies has raised an additional Rs 15 crore in a pre-series funding round. The round was led by existing investor Venture Catalyst, alongside new investors such as Finvolve through the IA Growth Opportunities Fund I and Brew Opportunities Fund, as well as Universal Group, KP Singhvi Group, and several high-net-worth individuals (HNIs).

 

This funding builds on a previous Rs 5 crore investment from USAID through SAMRIDH Health and LetsVenture, bringing the total raised in this round to Rs 20 crore.

With this new capital, Sunfox is set for rapid expansion in India and globally, focusing on scaling its flagship innovation, Spandan- a smartphone-based portable ECG device that provides clinically accurate 12-lead ECG readings, empowering users to detect heart attacks and monitor cardiac health in real time.

 

Used by over 30,000 individuals across 20 countries, Spandan has already saved more than 10,000 lives through early detection of heart conditions. This technology is proving critical as India confronts a surge in heart attacks post-COVID-19.

"This capital injection will enable us to scale rapidly, both in India and internationally," said CEO Rajat Jain. "It will fuel our growth and bring Spandan into homes and clinics worldwide. We envision a future where heart attacks are as preventable as fevers, with Spandan becoming as ubiquitous as a household thermometer."

Sunfox, operating from Dehradun, a Tier 2 city, is defying the norm that high-impact health tech innovations emerge only from metro cities. The company has established an advanced in-house R&D and manufacturing facility in the hilly state, capturing global attention from prestigious institutions such as Oxford and Wharton. Sunfox first gained widespread recognition when all five sharks—Namita Thapar, Peyush Bansal, Anupam Mittal, Vineeta Singh, and Ghazal Alagh—invested during its Shark Tank India debut.